Minimal-change disease (MCD) is an exceptional paraneoplastic presentation. We are describing the case of an ovarian paraneoplastic nephrotic syndrome. The kidney biopsy was consistent with MCD. Steroids and immunosuppressive therapy were given with no change in the nephroticrange proteinuria. A complete resolution of the nephrotic syndrome was soon observed with improvement of her clinical condition after five cycles of chemotherapy with paclitaxel and carboplatin and tumor-debulking surgery. Ovarian carcinoma paraneoplastic nephrotic syndrome secondary to MCD is an extremely rare event, which is important to recognize since it is responsive to the standard chemotherapy. © The Author 2011.
CITATION STYLE
González-Fontal, G. R., Restrepo, J. G., & Henao-Martínez, A. F. (2011). Minimal-change disease as a paraneoplastic syndrome in a patient with ovarian carcinoma. NDT Plus, 4(6), 427–429. https://doi.org/10.1093/ndtplus/sfr106
Mendeley helps you to discover research relevant for your work.